Trial intelligence / Profile preview

MyQURE: CNI Withdrawal in Kidney Transplant

NCT06493526Phase 4Recruiting

Start
Aug 2024
Primary completion
Dec 2026
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of mycophenolate mofetil in kidney transplant rejection. Started Aug 2024; status: recruiting.

02

Drugs

mycophenolate mofetil
03

Conditions

kidney transplant rejection

Beyond the preview

Go deeper on NCT06493526.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06493526.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call